Does the diabetes health plan have a differential impact on medication adherence among beneficiaries with fewer financial resources?

Huang, Cher X; Turk, Norman; Ettner, Susan L; Mangione, Carol M; Moin, Tannaz; O'Shea, Donna; Luchs, Robert; Chan, Charles; Duru, O Kenrik

Huang, Cher X; Turk, Norman; Ettner, Susan L; Mangione, Carol M; Moin, Tannaz; O'Shea, Donna; Luchs, Robert; Chan, Charles; Duru, O Kenrik.

Affiliation

Huang CX; Department of Internal Medicine, Massachusetts General Hospital, Boston.
Turk N; Department of Medicine, University of California, Los Angeles.
Ettner SL; Fielding School of Public Health, University of California, Los Angeles.
Mangione CM; Department of Medicine, University of California, Los Angeles.
Moin T; Fielding School of Public Health, University of California, Los Angeles.
O'Shea D; Department of Medicine, University of California, Los Angeles.
Luchs R; UnitedHealthcare, Minnetonka, MN.
Chan C; UnitedHealthcare, Minnetonka, MN.
Duru OK; UnitedHealthcare, Minnetonka, MN.

J Manag Care Spec Pharm ; 28(9): 948-957, 2022 Sep.

Article in En | MEDLINE | ID: mdl-36001105

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus / Metformin Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Manag Care Spec Pharm Year: 2022 Document type: Article Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google